Pharmaniaga Q1 profit rises
KUALA LUMPUR: Pharmaniaga Bhd’s first-quarter profit ended March this year rose marginally to RM18.92 million from RM18.38 million a year ago.
This was on the back of a 10.6 per cent rise in revenue to RM618.29 million, from RM559.20 million previously.
The company’s Indonesia business posted a turnaround with a profit of RM900,000 after registering a RM1 million loss a year ago.
This was due to higher contributions from improved operational efficiencies and reduced financial costs.
As at March 31, the group’s earnings per share was 7.3 sen, while net assets per share stood at RM2.10.
“We started off the year with stable performance. We saw higher demand from government hospitals and the private sector business,” said chairman Tan Sri Lodin Wok Kamaruddin in a statement yesterday.
“There was also better contributions from our overseas operations.
“We aim to tap opportunities in the domestic and international markets.”
Pharmaniaga board of directors has declared an interim dividend of four sen per share to be paid on June 7 to shareholders on the register as at May 31.
Pharmaniaga chairman Tan Sri Lodin Wok Kamaruddin